Today: October 21, 2018, 6:31 pm

Medacta Japan Highlights Success of 2nd Japanese M.O.R.E. Symposium 2017-11-10 00:02:01

- More than 300 medical professionals in attendance, with presentations from over 40 international surgeons

- Scientific sessions available for viewing on Medacta’s website

Medacta Japan Highlights Success of 2nd Japanese M.O.R.E. Symposium

For Medacta International, Inc.
Jill Bongiorni, 516-729-2250

Medacta Japan, a subsidiary of Medacta International, the privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today announced the success of its 2nd Japanese M.O.R.E Symposium, held on September 30 to October 1, 2017 and attended by over 300 medical professionals.

Reflecting Medacta’s ongoing commitment to continuous medical education, the event focused on how implant design, techniques and patient-specific treatment can improve outcomes and patient satisfaction in the changing orthopaedic landscape, positively impacting the sustainability of the healthcare system.

More than 40 Japanese orthopaedic surgery experts presented at the meeting, covering topics on innovation, education and healthcare sustainability, with important contributions from international experts who traveled from Australia, Europe and the United States to attend the event.

“Surgical education and training has been a pillar of Medacta’s mission and identity since the company began. We believe it is the foundation for optimal clinical outcomes and both patient and surgeon satisfaction,” said Francesco Siccardi, Executive Vice President of Medacta International. “The success and the incredible growth of Medacta Japan, in both joint and spine, is a further confirmation of that belief. We’re honored that a growing number of surgeons depend on us as a reliable partner, and we will do our best to maintain our vision for a bright future in Japan.”

For more information about the 2nd Japanese M.O.R.E. Symposium and Medacta, including scientific sessions, visit:

About Medacta International

Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a different approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 30 countries. To learn more about Medacta International, please visit or follow @Medacta on Twitter.

Press Information

Published by
Hossam Abdel-Kader
+43 1 9582319

# 503 Words
Related Articles
More From Business
Integra Certified Document Destruction Achieves Certification
ELKHART, INDIANA, UNITED STATES - October 11th, 2018 - Integra Certified Document Destruction(“Integra”) is proud to announce [..]
11th Asian Downstream Summit: Digital Transformation Awards [..]
SINGAPORE, Oct 10, 2018 - (ACN Newswire) - Voting for Asian Downstream Summit: Digital Transformation Awards 2018 has opened. The [..]
Indonesian Minister of SOEs officially closes 2018 [..]
Surabaya, East Java, Indonesia, Oct 9, 2018 - (ACN Newswire) - Minister of State-Owned Enterprises (SOEs) of Republic of Indonesia [..]
Coordinating Minister: SOEs getting more consolidated and [..]
Surabaya, East Java, Indonesia, Oct 5, 2018 - (ACN Newswire) - Coordinating Minister for Economic Affairs of Republic of Indonesia [..]
How to Buy Quality Custom Umbrellas
Guangzhou, China – 03 October 2018 - Huifeng Umbrella Co., Ltd offers all kinds of high quality umbrellas, featuring exclusive [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.